Synthetic Biology Market by Application like Artificial Tissue and Tissue Regeneration
Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022
(firmenpresse) - According to the new market research report ", published by MarketsandMarkets
Early buyers will receive 10% customization on reports (at) https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889
In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.
Browse and in-depth TOC on
162 - Tables
32 - Figures
214 - Pages
By application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) applications. The biofuel and renewable energy segment is estimated to grow at the highest CAGR during the forecast period. This high growth rate is attributed to the rising popularity of biofuels and the advantages of using genetically engineered organisms for the synthetic production of biofuels.
Speak to Analyst (at) https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=889
Key players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US). These players are increasingly collaborating, and partnering with companies to offer their synthetic oligonucleotides and to develop synthetic organisms.
About MarketsandMarkets
MarketsandMarkets
Our 850 fulltime analyst and SMEs at MarketsandMarkets"Growth Engagement Model ". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets"Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp
Our Website: https://www.marketsandmarkets.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.02.2019 - 13:16 Uhr
Sprache: Deutsch
News-ID 1546418
Anzahl Zeichen: 4819
contact information:
Contact person:
Town:
Phone: +44-800-368-9399
Kategorie:
Healthcare & Medical
Typ of Press Release: Success
type of sending: send
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 560 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Synthetic Biology Market by Application like Artificial Tissue and Tissue Regeneration
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
